NUTRA PHARMA CORP. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings
NUTRA PHARMA CORP. (NPHC) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings of $466 for the 6-month period ending 2019-06-30, per its 10-Q filed 2021-05-07.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 · last filed 2021-05-07
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2019-06-30 was $976.00.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2019-03-31 was -$510.00.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2016-12-31 was -$3.60K.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2016-09-30 was -$112.58K.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2017 was -$66.62K, a 158.57% decline from fiscal 2016.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2016 was $113.74K.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2015 was -$229.32K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|
| 2019-06-30 | $976.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-07 | $466.00 10-Q · filed 2021-05-07 | ||
| 2019-03-31 | -$510.00 10-Q · filed 2021-04-05 | |||
| 2018-12-31 | -$4.43K 10-Q · filed 2021-05-07 | |||
| 2017-12-31 | -$66.62K 10-K · filed 2021-02-05 | |||
| 2016-12-31 | -$3.60K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | -$116.18K derived: sum of 2 quarters · filed 2017-04-17 | $113.74K 10-K · filed 2017-04-17 | |
| 2016-09-30 | -$112.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-22 | $117.34K 10-Q · filed 2016-11-22 | ||
| 2016-06-30 | $229.92K 10-Q · filed 2016-08-22 | |||
| 2015-12-31 | -$229.32K 10-K · filed 2017-04-17 |